ClinicalTrials.Veeva

Menu

Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects

U

University of Vic - Central University of Catalonia

Status

Completed

Conditions

Injuries
Biomechanics
Caffeine
Physical Activity
Fatigue

Treatments

Dietary Supplement: Caffeine.
Drug: Cellulose.

Study type

Interventional

Funder types

Other

Identifiers

NCT06039358
CAFBIOM001

Details and patient eligibility

About

Caffeine is one of the few supplements that have enough scientific evidence to state that can notably improve performance, as different remarkable organizations in the sports nutrition context have classified it as an ergogenic aid with strong evidence regarding its efficacy and that is apparently safe. The beneficial effect of this substance on physical and cognitive performance has been identified in aerobic and anaerobic efforts, including aerobic and muscular endurance, power, or strength.

However, it seems that the benefits of caffeine are usually measured only by its effect on performance, while a comprehensive analysis of its impact on other aspects of the movement technique of the exercise is not considered. Therefore, although caffeine generates better performance, a null or negative effect may occur on technique execution. As such, some consequences might arise (e.g., an increase in injury risk or a decrease in energy efficiency).

The objective of this randomized controlled trial is to assess the influence of caffeine on certain biomechanical parameters of the technique of physical exercises in circumstances without fatigue and under neuromuscular fatigue. The study hypothesis is that caffeine generates modifications in the technical execution of certain movements in fatigued and unfatigued circumstances due to its physiological effects, which may be beneficial for performance and injury prevention.

The participants will have to attend 5 sessions (enrollment, familiarization, control, placebo, and caffeine), at least 7 days apart. In the last 3 sessions, different measurements will be done to their technique while jumping, squatting, and running, without fatigue and with it. Other data will be collected throughout the study to contextualize and analyze in more detail the obtained information.

Full description

A detailed description of the study can be found in the protocol uploaded with this registry entry.

Enrollment

15 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • An uninterrupted training time of at least 1 year in the subjects' regular exercise modality (either the person is still training or interrupted the training period during the last year, and with no more than 4 months of detraining).
  • A good exercise technique of the assessed movement patterns (running, squatting, and jumping).

Exclusion criteria

  • Not being 18-30 years old.
  • Having any relevant medical condition.
  • Pregnancy.
  • Smoking.
  • Regular medication consumption / Medication consumption the days before the sessions during the study.
  • Other supplementation regular consumption / Other supplementation consumption during the study (excluding sports foods, provided that their goal and nutrients have the objective of substituting the ingestion of regular food (e.g., isotonic drinks, carbohydrates gels, protein powder...), without adding other components that may act as ergogenic substances).
  • Habitual caffeine consumption of >25mg/day-0,99mg/kg/day.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

15 participants in 2 patient groups

Control - caffeine - placebo.
Experimental group
Description:
The order of the assessed sessions will be first the control one, then the caffeine one, and then the placebo one.
Treatment:
Drug: Cellulose.
Dietary Supplement: Caffeine.
Control - placebo - caffeine.
Experimental group
Description:
The order of the assessed sessions will be first the control one, then the placebo one, and then the caffeine one.
Treatment:
Drug: Cellulose.
Dietary Supplement: Caffeine.

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Javier Peña López, Ph.D.; Arnau Baena Riera, MSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems